Why is NRXP Down Today?
About NRX Pharmaceuticals, Inc. Common Stock
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an...
Overall Confidence: 60%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -0.6%
Market Comparison
Quick Trade Ideas
Options strategies to consider for NRXP's -6% move
No Options Available
NRXP doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get NRXP Alerts
We'll notify you when NRXP's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
NRXP has moved more than 3.0% down on 64 occasions in the past year.
Frequently Asked Questions
Why is NRXP stock down today?
This stock is significantly underperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.
Is NRXP stock a buy or sell right now?
Based on current analysis, NRXP shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the NRXP stock price target?
NRXP is currently trading at $2.29. Based on today's momentum, the expected short-term range is $2.22 - $2.34. See long-term price prediction →
Will NRXP stock continue falling?
Our analysis shows a 45% probability that NRXP's move continues in the next 1-3 days. Key level to watch: $2.18 (support).
Is NRXP stock oversold or overbought?
NRXP's RSI (Relative Strength Index) is currently at 39.8. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for NRXP stock?
NRXP's 10-day momentum indicator is at -0.38. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is NRXP outperforming or underperforming the market?
NRXP (-6.15%) is currently significantly underperforming the market (-5.8% vs SPY). Today, the S&P 500 (SPY) is down -0.35%, and Nasdaq (QQQ) is down -0.32%.
What does MACD indicate for NRXP?
NRXP's MACD (-0.14) is currently above the signal line (-0.15), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 33.4) is strong.
Is NRXP in an uptrend or downtrend?
Based on moving average analysis, NRXP is in a bearish trend. The price ($2.29) is trading below both the 20-day SMA ($2.46) and 50-day SMA ($2.85). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis